Skip to main content
SpringerLink
Log in

Which atypical antipsychotic most costly in bipolar disorder?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Which atypical antipsychotic most costly in bipolar disorder?. Pharmacoecon. Outcomes News 479, 4 (2005). https://doi.org/10.2165/00151234-200504790-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200504790-00011

Keywords

Search

Navigation